LYMEPAK FDA approval date

The FDA approved LYMEPAK on 15 Jun 2018.

FDA approval date
15 Jun 2018

Drug identity has not yet been verified against registry records

Also recorded as DOXYCYCLINE HYCLATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2018-06-15DayLYMEPAKFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA209844", "applicant_as_listed_by_fda": "CHARTWELL PHARMA", "brand_names": ["LYMEPAK"], "active_ingredients": ["DOXYCYCLINE HYCLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20180615", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026